サマリー

産後出血（PPH）は、多くの場合、産後24時間以内に500mlまたは1,000ml以上の血液が失われることと定義されています。
市場分析とインサイト世界の産後出血治療薬市場
COVID-19のパンデミックにより、産後出血治療薬の世界市場規模は2022年に100万米ドルと推定され、検討期間中のCAGRは%で2028年までに再調整して100万米ドルになると予測されています。この健康危機による経済的変化を十分に考慮した上で、2021年の産後出血治療薬の世界市場の％を占める「経口」は、COVID-19後の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、病院のセグメントは、この予測期間を通じて％CAGRで変化しています。
中国の産後出血治療薬の市場規模は2021年に百万米ドル、米国と欧州の産後出血治療薬はそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には％、中国と欧州はそれぞれ％と％で、中国の割合は2028年には％に達し、分析期間中のCAGRは％になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの産後出血治療薬市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%となっています。
産後出血治療薬の世界的な主要メーカーには、Merck、Pfizer、Novartis、Lupin Pharmaceuticals、Hikma Pharmaceuticals、Teva、Fresenius Kabiなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界の産後出血薬のスコープとセグメント
産後出血薬市場は、タイプ別、アプリケーション別に分類されています。世界の産後出血薬市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
経口投与
注射薬
アプリケーション別セグメント
病院
クリニック
その他
会社別
メルク
ファイザー
ノバルティス
ルパン製薬
ヒグマ・ファーマシューティカルズ
テバ
フレゼニウス・カビ
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Postpartum Bleeding Drug Product Introduction
1.2 Market by Type
1.2.1 Global Postpartum Bleeding Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Postpartum Bleeding Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Postpartum Bleeding Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Postpartum Bleeding Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Postpartum Bleeding Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Postpartum Bleeding Drug Sales by Region
2.4.1 Global Postpartum Bleeding Drug Sales by Region (2017-2022)
2.4.2 Global Sales Postpartum Bleeding Drug by Region (2023-2028)
2.5 Global Postpartum Bleeding Drug Revenue by Region
2.5.1 Global Postpartum Bleeding Drug Revenue by Region (2017-2022)
2.5.2 Global Postpartum Bleeding Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Postpartum Bleeding Drug Sales by Manufacturers
3.1.1 Global Top Postpartum Bleeding Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Postpartum Bleeding Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Postpartum Bleeding Drug in 2021
3.2 Global Postpartum Bleeding Drug Revenue by Manufacturers
3.2.1 Global Postpartum Bleeding Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Postpartum Bleeding Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Postpartum Bleeding Drug Revenue in 2021
3.3 Global Postpartum Bleeding Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Postpartum Bleeding Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Postpartum Bleeding Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Postpartum Bleeding Drug Sales by Type
4.1.1 Global Postpartum Bleeding Drug Historical Sales by Type (2017-2022)
4.1.2 Global Postpartum Bleeding Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Postpartum Bleeding Drug Sales Market Share by Type (2017-2028)
4.2 Global Postpartum Bleeding Drug Revenue by Type
4.2.1 Global Postpartum Bleeding Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Postpartum Bleeding Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Postpartum Bleeding Drug Revenue Market Share by Type (2017-2028)
4.3 Global Postpartum Bleeding Drug Price by Type
4.3.1 Global Postpartum Bleeding Drug Price by Type (2017-2022)
4.3.2 Global Postpartum Bleeding Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Postpartum Bleeding Drug Sales by Application
5.1.1 Global Postpartum Bleeding Drug Historical Sales by Application (2017-2022)
5.1.2 Global Postpartum Bleeding Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Postpartum Bleeding Drug Sales Market Share by Application (2017-2028)
5.2 Global Postpartum Bleeding Drug Revenue by Application
5.2.1 Global Postpartum Bleeding Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Postpartum Bleeding Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Postpartum Bleeding Drug Revenue Market Share by Application (2017-2028)
5.3 Global Postpartum Bleeding Drug Price by Application
5.3.1 Global Postpartum Bleeding Drug Price by Application (2017-2022)
5.3.2 Global Postpartum Bleeding Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Postpartum Bleeding Drug Market Size by Type
6.1.1 North America Postpartum Bleeding Drug Sales by Type (2017-2028)
6.1.2 North America Postpartum Bleeding Drug Revenue by Type (2017-2028)
6.2 North America Postpartum Bleeding Drug Market Size by Application
6.2.1 North America Postpartum Bleeding Drug Sales by Application (2017-2028)
6.2.2 North America Postpartum Bleeding Drug Revenue by Application (2017-2028)
6.3 North America Postpartum Bleeding Drug Market Size by Country
6.3.1 North America Postpartum Bleeding Drug Sales by Country (2017-2028)
6.3.2 North America Postpartum Bleeding Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Postpartum Bleeding Drug Market Size by Type
7.1.1 Europe Postpartum Bleeding Drug Sales by Type (2017-2028)
7.1.2 Europe Postpartum Bleeding Drug Revenue by Type (2017-2028)
7.2 Europe Postpartum Bleeding Drug Market Size by Application
7.2.1 Europe Postpartum Bleeding Drug Sales by Application (2017-2028)
7.2.2 Europe Postpartum Bleeding Drug Revenue by Application (2017-2028)
7.3 Europe Postpartum Bleeding Drug Market Size by Country
7.3.1 Europe Postpartum Bleeding Drug Sales by Country (2017-2028)
7.3.2 Europe Postpartum Bleeding Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Postpartum Bleeding Drug Market Size by Type
8.1.1 Asia Pacific Postpartum Bleeding Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Postpartum Bleeding Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Postpartum Bleeding Drug Market Size by Application
8.2.1 Asia Pacific Postpartum Bleeding Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Postpartum Bleeding Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Postpartum Bleeding Drug Market Size by Region
8.3.1 Asia Pacific Postpartum Bleeding Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Postpartum Bleeding Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Postpartum Bleeding Drug Market Size by Type
9.1.1 Latin America Postpartum Bleeding Drug Sales by Type (2017-2028)
9.1.2 Latin America Postpartum Bleeding Drug Revenue by Type (2017-2028)
9.2 Latin America Postpartum Bleeding Drug Market Size by Application
9.2.1 Latin America Postpartum Bleeding Drug Sales by Application (2017-2028)
9.2.2 Latin America Postpartum Bleeding Drug Revenue by Application (2017-2028)
9.3 Latin America Postpartum Bleeding Drug Market Size by Country
9.3.1 Latin America Postpartum Bleeding Drug Sales by Country (2017-2028)
9.3.2 Latin America Postpartum Bleeding Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Postpartum Bleeding Drug Market Size by Type
10.1.1 Middle East and Africa Postpartum Bleeding Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Postpartum Bleeding Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Postpartum Bleeding Drug Market Size by Application
10.2.1 Middle East and Africa Postpartum Bleeding Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Postpartum Bleeding Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Postpartum Bleeding Drug Market Size by Country
10.3.1 Middle East and Africa Postpartum Bleeding Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Postpartum Bleeding Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Lupin Pharmaceuticals
11.4.1 Lupin Pharmaceuticals Corporation Information
11.4.2 Lupin Pharmaceuticals Overview
11.4.3 Lupin Pharmaceuticals Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lupin Pharmaceuticals Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lupin Pharmaceuticals Recent Developments
11.5 Hikma Pharmaceuticals
11.5.1 Hikma Pharmaceuticals Corporation Information
11.5.2 Hikma Pharmaceuticals Overview
11.5.3 Hikma Pharmaceuticals Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hikma Pharmaceuticals Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Pharmaceuticals Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Corporation Information
11.7.2 Fresenius Kabi Overview
11.7.3 Fresenius Kabi Postpartum Bleeding Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fresenius Kabi Postpartum Bleeding Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fresenius Kabi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Postpartum Bleeding Drug Industry Chain Analysis
12.2 Postpartum Bleeding Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Postpartum Bleeding Drug Production Mode & Process
12.4 Postpartum Bleeding Drug Sales and Marketing
12.4.1 Postpartum Bleeding Drug Sales Channels
12.4.2 Postpartum Bleeding Drug Distributors
12.5 Postpartum Bleeding Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Postpartum Bleeding Drug Industry Trends
13.2 Postpartum Bleeding Drug Market Drivers
13.3 Postpartum Bleeding Drug Market Challenges
13.4 Postpartum Bleeding Drug Market Restraints
14 Key Findings in The Global Postpartum Bleeding Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer